289 related articles for article (PubMed ID: 9718512)
1. Financing structure dynamics and other determinants of Medicaid pharmaceutical expenditures, 1993-1996.
Okunade AA
J Health Care Finance; 1998; 25(1):59-71. PubMed ID: 9718512
[TBL] [Abstract][Full Text] [Related]
2. Trends in prescription drug expenditures by Medicaid enrollees.
Banthin JS; Miller GE
Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
[TBL] [Abstract][Full Text] [Related]
3. Unintended outcomes of medicaid drug cost-containment policies on the chronically mentally ill.
Soumerai S
J Clin Psychiatry; 2003; 64 Suppl 17():19-22. PubMed ID: 14680423
[TBL] [Abstract][Full Text] [Related]
4. States' control of prescription drug spending: a heterogeneous approach.
Morden NE; Sullivan SD
Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
[TBL] [Abstract][Full Text] [Related]
5. First 6 months of Medicaid data.
Dobson A; Scharff J; Corder L
Natl Med Care Util Expend Surv B; 1986 Dec; (1):1-81. PubMed ID: 10313515
[TBL] [Abstract][Full Text] [Related]
6. Recent trends in Medicaid expenditures.
Buck JA; Klemm J
Health Care Financ Rev Annu Suppl; 1992; ():271-83. PubMed ID: 10131710
[TBL] [Abstract][Full Text] [Related]
7. Providers yet to feel Medicaid cost rise.
Jaklevic MC
Mod Healthc; 2000 Oct; 30(45):44. PubMed ID: 12025324
[No Abstract] [Full Text] [Related]
8. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
Dale SB; Verdier JM
Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
[No Abstract] [Full Text] [Related]
9. A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
Soumerai SB; Ross-Degnan D; Fortess EE; Abelson J
Milbank Q; 1993; 71(2):217-52. PubMed ID: 8510601
[TBL] [Abstract][Full Text] [Related]
10. Medicaid managed care: state experiences.
Rowland D
Bull N Y Acad Med; 1996; 73(2 Suppl):496-505. PubMed ID: 8988302
[No Abstract] [Full Text] [Related]
11. Variation in state Medicaid expenditures 1984-92: the behavioral impact of the matching federal grant.
Adams EK; Wade M
J Health Care Finance; 2000; 27(1):29-43. PubMed ID: 10961830
[TBL] [Abstract][Full Text] [Related]
12. Managing Medicaid drug expenditures.
Sudovar SG; Rein SD
J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
[No Abstract] [Full Text] [Related]
13. Differences in the cost of antidepressants across state Medicaid programs.
Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
[TBL] [Abstract][Full Text] [Related]
14. The effect of Medicaid family planning expansions on unplanned births.
Lindrooth RC; McCullough JS
Womens Health Issues; 2007; 17(2):66-74. PubMed ID: 17403463
[TBL] [Abstract][Full Text] [Related]
15. The Medicaid outlook for Michigan and beyond.
Ellis ER
Mich Health Hosp; 2003; 39(2):8-11. PubMed ID: 12685355
[No Abstract] [Full Text] [Related]
16. DataLine. Lower Medicaid costs, stronger economy strengthen state budgets.
J Am Health Policy; 1994; 4(4):39-40. PubMed ID: 10136681
[No Abstract] [Full Text] [Related]
17. Budget deficits threaten to shut out Medicaid benefits.
Pallarito K
Mod Healthc; 1991 Apr; 21(16):26-8, 30-1. PubMed ID: 10113575
[TBL] [Abstract][Full Text] [Related]
18. Falling state budgets collide with rising Medicaid costs.
Scott JS
Healthc Financ Manage; 2001 Nov; 55(11):28-9. PubMed ID: 11715377
[No Abstract] [Full Text] [Related]
19. Cluster analysis of state Medicaid prescription drug benefit programs based on potential determinants of per capita drug expenditure.
Roy S; Madhavan SS
Res Social Adm Pharm; 2009 Mar; 5(1):51-62. PubMed ID: 19285289
[TBL] [Abstract][Full Text] [Related]
20. State variation in Medicaid spending: hard to justify.
Holahan J
Health Aff (Millwood); 2007; 26(6):w667-9. PubMed ID: 17878183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
